Abbasi Sh, Rezaei J, Bazi F, Alsadat Mousavi M, Rassouli S, Zamanpour Z, Hosseini E, Noori M, Hamidi MZ. Association between metabolic syndrome and risk of endometrial cancer; a systematic review and meta-analysis. Immunopathol Persa. 2025;11(2): e41724. https://doi.org/10.34172/ipp.2025.41724.
Fakour F, Bodaghi N, Hajizadeh Fallah H, Etezadi A. Survey of serum level of high risk human papilloma virus antibodies in patients with cervical cancer and CIN I, II, III in pap smears. 2016.
Vakili-Ojarood M, Naseri A, Shirinzadeh-Dastgiri A, Saberi A, HaghighiKian SM, Rahmani A, et al. Ethical considerations and equipoise in cancer surgery. Indian J Surg Oncol. 2024;15(Suppl 3):363–73.
Aghaei HN, Azimi P, Shahzadi S, Azhari S, Mohammadi HR, Alizadeh P, et al. Outcome measures of functionality, social interaction, and pain in patients with cervical spondylotic myelopathy: a validation study for the Iranian version of the Copenhagen neck functional disability scale. Asian Spine Journal. 2015;9(6):901.
Perrotta AR, Borrelli GM, Martins CO, Kallas EG, Sanabani SS, Griffith LG, et al. The vaginal microbiome as a tool to predict rASRM stage of disease in endometriosis: a pilot study. Reprod Sci. 2020;27:1064–73.
Article CAS PubMed Google Scholar
López-Urrutia E, Bustamante Montes LP, de Guevara L, Cervantes D, Pérez-Plasencia C, Campos-Parra AD. Crosstalk between long non-coding RNAs, micro-RNAs and mRNAs: deciphering molecular mechanisms of master regulators in cancer. Front Oncol. 2019;9:669.
Article PubMed PubMed Central Google Scholar
Peng W-X, Koirala P, Mo Y-Y. LncRNA-mediated regulation of cell signaling in cancer. Oncogene. 2017;36(41):5661–7.
Article CAS PubMed PubMed Central Google Scholar
Bhan A, Soleimani M, Mandal SS. Long noncoding RNA and cancer: a new paradigm. Can Res. 2017;77(15):3965–81.
HaghighiKian SM, Shirinzadeh-Dastgiri A, Vakili-Ojarood M, Naseri A, Barahman M, Saberi A, et al. A holistic approach to implementing artificial intelligence in lung cancer. Indian J Surg Oncol. 2024:1–22.
Babadi AJ, Kouti RN, Zeinali M, Lordejani MA, Marandi HJ, Farhadi E. Effect of Cervical Index changes on cervical pain. J Iran Med Council. 2024. https://doi.org/10.18502/jimc.v7i3.15731.
Chen L, Dzakah EE, Shan G. Targetable long non-coding RNAs in cancer treatments. Cancer Lett. 2018;418:119–24.
Article CAS PubMed Google Scholar
Fu D, Shi Y, Liu J-B, Wu T-M, Jia C-Y, Yang H-Q, et al. Targeting long non-coding RNA to therapeutically regulate gene expression in cancer. Mol Therapy-Nucleic Acids. 2020;21:712–24.
Jiang W, Xia J, Xie S, Zou R, Pan S, Wang Z-w, et al. Long non-coding RNAs as a determinant of cancer drug resistance: Towards the overcoming of chemoresistance via modulation of lncRNAs. Drug Resist Updates. 2020;50:100683.
Khayat Kashani HR, Alizadeh P, Salimi S, Habtemariam S, Khayatkashani M, Tewari D. Epidemiologic profile and outcome of primary pediatric brain tumors in Iran: retrospective study and literature review. Child’s Nervous Syst. 2022;38:1–8.
Guo C, Song W, Sun P, Jin L, Dai H. LncRNA-GAS5 induces PTEN expression through inhibiting miR-103 in endometrial cancer cells. J Biomed Sci. 2015;22(1):1–9.
Fang X, Zhong G, Wang Y, Lin Z, Lin R, Yao T. Low GAS5 expression may predict poor survival and cisplatin resistance in cervical cancer. Cell Death Dis. 2020;11(7):531.
Article CAS PubMed PubMed Central Google Scholar
Lambrou GI, Hatziagapiou K, Zaravinos A. The non-coding RNA GAS5 and its role in tumor therapy-induced resistance. Int J Mol Sci. 2020;21(20):7633.
Article CAS PubMed PubMed Central Google Scholar
Liu Y, Ma J, Cui D, Fei X, Lv Y, Lin J. LncRNA MEG3-210 regulates endometrial stromal cells migration, invasion and apoptosis through p38 MAPK and PKA/SERCA2 signalling via interaction with Galectin-1 in endometriosis. Mol Cell Endocrinol. 2020;513: 110870.
Article CAS PubMed Google Scholar
Zhang P, Shi B, Zhou M, Jiang H, Zhang H, Pan X, et al. Galectin-1 overexpression promotes progression and chemoresistance to cisplatin in epithelial ovarian cancer. Cell Death Dis. 2014;5(1):e991-e.
Article CAS PubMed PubMed Central Google Scholar
Chung L-Y, Tang S-J, Sun G-H, Chou T-Y, Yeh T-S, Yu S-L, et al. Galectin-1 promotes lung cancer progression and chemoresistance by upregulating p38 MAPK, ERK, and cyclooxygenase-2. Clin Cancer Res. 2012;18(15):4037–47.
Article CAS PubMed Google Scholar
Lv C, Sun J, Ye Y, Lin Z, Li H, Liu Y, et al. Long noncoding RNA EIF1AX-AS1 promotes endometrial cancer cell apoptosis by affecting EIF1AX mRNA stabilization. Cancer Sci. 2022;113(4):1277–91.
Article CAS PubMed PubMed Central Google Scholar
Shi F, Wang T, Liu Z, Zhang Y, Wang J, Zhang K, et al. LncRNA miR143HG up-regulates p53 in endometrial carcinoma by sponging miR-125a. Cancer Manage Res. 2019;11:10117–23.
Chen JJ, Liu SX, Chen MZ, Zhao ZY. Has-miR-125a and 125b are induced by treatment with cisplatin in nasopharyngeal carcinoma and inhibit apoptosis in a p53-dependent manner by targeting p53 mRNA. Mol Med Rep. 2015;12(3):3569–74.
Article CAS PubMed Google Scholar
Lu H, Ju D, Yang G, Zhu L, Yang X, Li J, et al. Targeting cancer stem cell signature gene SMOC-2 Overcomes chemoresistance and inhibits cell proliferation of endometrial carcinoma. EBioMedicine. 2019;40:276–89.
Zhang X-H, Hu P, Xie Y-Q, Kang Y-J, Li M. Long noncoding RNA HOTAIR promotes endometrial carcinoma cell proliferation by binding to PTEN via the activating phosphatidylinositol 3-kinase/Akt signaling pathway. Mol Cell Biol. 2019;39(23):e00251-e319.
Article CAS PubMed PubMed Central Google Scholar
Xin W, Gao X, Zhao S, Zhao P, Yu H, Wu Q, et al. LncRNA RP11–395G23. 3 suppresses the endometrial cancer progression via regulating microRNA-205–5p/PTEN axis. Am J Transl Res. 2020;12(8):4422.
CAS PubMed PubMed Central Google Scholar
Chen Q, Schatz C, Cen Y, Chen X, Haybaeck J, Li B. LncRNA TUG1 promotes the migration and invasion in type I endometrial carcinoma cells by regulating E-N cadherin switch. Taiwan J Obstet Gynecol. 2022;61(5):780–7.
Ranjbary AG, Saleh GK, Azimi M, Karimian F, Mehrzad J, Zohdi J. Superparamagnetic iron oxide nanoparticles induce apoptosis in HT-29 cells by stimulating oxidative stress and damaging DNA. Biol Trace Elem Res. 2023;201(3):1163–73.
Article CAS PubMed Google Scholar
Dong P, Wang F, Taheri M, Xiong Y, Ihira K, Kobayashi N, et al. Long non-coding RNA TMPO-AS1 promotes GLUT1-mediated glycolysis and paclitaxel resistance in endometrial cancer cells by interacting with miR-140 and miR-143. Front Oncol. 2022;12: 912935.
Article CAS PubMed PubMed Central Google Scholar
Shen J, Yuan Z, Sheng J, Feng X, Wang H, Wang Y, et al. Long non-coding RNA NNT-AS1 positively regulates NPM1 expression to affect the proliferation of estrogen-mediated endometrial carcinoma by interacting. J Cancer. 2022;13(1):112.
Article CAS PubMed PubMed Central Google Scholar
Zeng D, Xiao Y, Zhu J, Peng C, Liang W, Lin H. Knockdown of nucleophosmin 1 suppresses proliferation of triple-negative breast cancer cells through activating CDH1/Skp2/p27kip1 pathway. Cancer Manag Res. 2018;11:143–56. https://doi.org/10.2147/CMAR.S191176.
Article PubMed PubMed Central Google Scholar
Xing Y, Sun X, Li F, Jiang X, Jiang A, Li X, et al. Long non-coding RNA (lncRNA) HOXB-AS3 promotes cell proliferation and inhibits apoptosis by regulating ADAM9 expression through targeting miR-498-5p in endometrial carcinoma. J Int Med Res. 2021;49(6):03000605211013548.
Article CAS PubMed PubMed Central Google Scholar
Liu R, Gu J, Jiang P, Zheng Y, Liu X, Jiang X, et al. DNMT1–MicroRNA126 epigenetic circuit contributes to esophageal squamous cell carcinoma growth via ADAM9–EGFR–AKT signaling. Clin Cancer Res. 2015;21(4):854–63.
留言 (0)